Matt Fust

Senior Advisor, Finance at Crinetics Pharmaceuticals, Inc.

Matt Fust

Matt Fust

Senior Advisor, Finance at Crinetics Pharmaceuticals, Inc.

Overview
Career Highlights

Onyx Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc.
Perlegen Sciences, Inc.

RelSci Relationships

889

Number of Boards

8

Birthday

1965

Age

54

Contact Data
Trying to get in touch with Matt Fust? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Matt Fust likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Operating Officer at Jazz Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman of the Board, Chief Executive Officer, Co-Founder at Dermira, Inc.

Relationship likelihood: Strong

Founder & Chief Medical Officer at Dermira, Inc.

Relationship likelihood: Strong

Co-Founder at MacroGenics, Inc.

Relationship likelihood: Strong

Executive Chair at Atara Biotherapeutics, Inc.

Relationship likelihood: Strong

President, Research & Development, Senior Vice President & Chief Scientific Officer at Amarin Corporation Plc

Relationship likelihood: Strong

Venture Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Consultant at Sunesis Pharmaceuticals, Inc.

Relationship likelihood: Strong

Professional at Dermira, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Pinta Biotherapeutics, Inc.

Relationship likelihood: Strong

Paths to Matt Fust
Potential Connections via
Relationship Science
You
Matt Fust
Senior Advisor, Finance at Crinetics Pharmaceuticals, Inc.
Education
Masters in Business Administration
Class of 1991

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

BA Unknown

The University of Minnesota, Twin Cities (Minnesota, U of M, or The U) is a public research university located in Minneapolis and St. Paul, Minnesota, United States, with the Minneapolis and St. Paul campuses being approximately 5 miles (8.0 km) apart. It is the oldest and largest campus within the University of Minnesota system and has the sixth-largest main campus student body in the United States, with 51,853 students in 2012–2013. The university is broadly organized into 19 colleges and schools, and it has sister campuses in Crookston, Duluth, Morris, and Rochester.

Career History
Senior Advisor, Finance
2018 - Current

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Professional
2014 - Current

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.

Professional
2014 - Current

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe. Our innovative product candidates leverage our fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Our Dual-Affinity Re-Targeting (DART™) platform enables us to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Our Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells; and Our Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy.

Boards & Committees
Member, Board of Directors
2018 - Current

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Member, Board of Directors
2017 - Current

Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA.

Independent Director
2014 - Current

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $2,499
2014

Promoting the bicycle for everyday transportation.

$500 - $999
2013

Promoting the bicycle for everyday transportation.

$500 - $999
2012

Promoting the bicycle for everyday transportation.

Political Donations
$500
2012

Distinguished Professor of Health Promotion & Entrepreneurship at The Ohio State University - College of Nursing

$500
2012

Senator from Virginia

$1,000
2012

Former President of United States

Investments
Details Hidden

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Xyrem, Erwinaze, Quadramet, Caphosol, ProstaScint, LuvoxCR and Parcopa. The firm focuses on the development and commercialization of pharmaceutical products to meet important unmet medical needs in neurology and psychiatry. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matt Fust. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matt Fust's profile does not indicate a business or promotional relationship of any kind between RelSci and Matt Fust.